Japan
· Delayed Price · Currency is JPY OncoTherapy Science Statistics
Total Valuation
TYO:4564 has a market cap or net worth of JPY 6.34 billion. The enterprise value is 5.39 billion.
| Market Cap | 6.34B |
| Enterprise Value | 5.39B |
Important Dates
The next estimated earnings date is Friday, May 9, 2025.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TYO:4564 has 275.64 million shares outstanding. The number of shares has increased by 19.95% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 275.64M |
| Shares Change (YoY) | +19.95% |
| Shares Change (QoQ) | +1.22% |
| Owned by Insiders (%) | 10.67% |
| Owned by Institutions (%) | -1.85% |
| Float | 246.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.97 |
| PB Ratio | 7.66 |
| P/TBV Ratio | 7.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.30 |
| EV / Sales | 7.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.06
| Current Ratio | 4.06 |
| Quick Ratio | 3.56 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -137.29% and return on invested capital (ROIC) is -71.31%.
| Return on Equity (ROE) | -137.29% |
| Return on Assets (ROA) | -48.89% |
| Return on Invested Capital (ROIC) | -71.31% |
| Return on Capital Employed (ROCE) | -89.90% |
| Revenue Per Employee | 13.09M |
| Profits Per Employee | -18.85M |
| Employee Count | 54 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 12.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.78% in the last 52 weeks. The beta is 0.19, so TYO:4564's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | +27.78% |
| 50-Day Moving Average | 26.06 |
| 200-Day Moving Average | 32.65 |
| Relative Strength Index (RSI) | 42.07 |
| Average Volume (20 Days) | 2,330,310 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TYO:4564 had revenue of JPY 707.00 million and -1.02 billion in losses. Loss per share was -4.11.
| Revenue | 707.00M |
| Gross Profit | -564.00M |
| Operating Income | -846.00M |
| Pretax Income | -1.02B |
| Net Income | -1.02B |
| EBITDA | n/a |
| EBIT | -846.00M |
| Loss Per Share | -4.11 |
Balance Sheet
The company has 945.00 million in cash and n/a in debt, giving a net cash position of 945.00 million or 3.43 per share.
| Cash & Cash Equivalents | 945.00M |
| Total Debt | n/a |
| Net Cash | 945.00M |
| Net Cash Per Share | 3.43 |
| Equity (Book Value) | 828.00M |
| Book Value Per Share | 3.05 |
| Working Capital | 891.00M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is -79.77%, with operating and profit margins of -119.66% and -143.99%.
| Gross Margin | -79.77% |
| Operating Margin | -119.66% |
| Pretax Margin | -143.71% |
| Profit Margin | -143.99% |
| EBITDA Margin | n/a |
| EBIT Margin | -119.66% |
| FCF Margin | n/a |
Dividends & Yields
TYO:4564 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.95% |
| Shareholder Yield | -19.95% |
| Earnings Yield | -16.06% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 26, 2013. It was a forward split with a ratio of 500.
| Last Split Date | Sep 26, 2013 |
| Split Type | Forward |
| Split Ratio | 500 |
Scores
TYO:4564 has an Altman Z-Score of -20.25. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -20.25 |
| Piotroski F-Score | n/a |